0001179110-14-011434.txt : 20140703 0001179110-14-011434.hdr.sgml : 20140703 20140703132643 ACCESSION NUMBER: 0001179110-14-011434 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140701 FILED AS OF DATE: 20140703 DATE AS OF CHANGE: 20140703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SYNTA PHARMACEUTICALS CORP CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 45 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-274-8200 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: REARDON WILLIAM S CENTRAL INDEX KEY: 0001212646 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 14959893 MAIL ADDRESS: STREET 1: 9 STEAMBOAT LANE CITY: HINGHAM STATE: MA ZIP: 02043 4 1 edgar.xml FORM 4 - X0306 4 2014-07-01 0 0001157601 SYNTA PHARMACEUTICALS CORP SNTA 0001212646 REARDON WILLIAM S C/O SYNTA PHARMACEUTICALS CORP. 45 HARTWELL AVENUE LEXINGTON MA 02421 1 0 0 0 Common Stock 2014-07-01 4 A 0 4878 0 A 41439 D Director Stock Option (Right to Buy) 4.10 2014-07-01 4 A 0 10000 0 A 2024-07-01 Common Stock 10000 10000 D Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 25% of the shares on each of September 30, 2014, December 31, 2014, March 31, 2015 and June 30, 2015, provided the Reporting Person continues to serve as a director of the Issuer on such date. The option vests as to 25% of the shares on each of September 30, 2014, December 31, 2014, March 31, 2015 and June 30, 2015, provided the Reporting Person continues to serve as a director of the Issuer on such date. /s/ Garrett M. Winslow, Attorney-in-Fact 2014-07-03